Tissue Engineering: Focus on the Cardiovascular System - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 184

46. Wang Y, Feng C, Xue J, Sun A, Li J, Wu J. Adenovirus-mediated hypoxia-inducible
factor 1alpha double-mutant promotes differentiation of bone marrow stem cells
to cardiomyocytes. J Physiol Sci. Nov 2009; 59(6): 413-420.
47. Yoon J, Choi SC, Park CY, Choi JH, Kim YI, Shim WJ, Lim DS. Bone marrow-
derived side population cells are capable of functional cardiomyogenic differen-
tiation. Mol Cells. Apr 30 2008; 25(2): 216-223.
48. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R,
Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate
infarcted myocardium. Nature. Apr 5 2001; 410(6829): 701-705.
49. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B,
Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted
heart, improving function and survival. Proc Natl Acad Sci USA. Aug 28 2001;
98(18): 10344-10349.
50. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, et al.
Bone marrow cells differentiate in cardiac cell lineages after infarction indepen-
dently of cell fusion. Circ Res. Jan 7 2005; 96(1): 127-137.
51. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, et al.
Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci
USA. Nov 6 2007; 104(45): 17783-17788.
52. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC.
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic
myocardium. Nature. Apr 8 2004; 428(6983): 668-673.
53. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M,
Pasumarthi KB, et al. Haematopoietic stem cells do not transdifferentiate into
cardiac myocytes in myocardial infarcts. Nature. Apr 8 2004; 428(6983): 664-668.
54. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, Taneera J,
Fleischmann BK, Jacobsen SE. Bone marrow-derived hematopoietic cells gener-
ate cardiomyocytes at a low frequency through cell fusion, but not transdiffer-
entiation. Nat Med. May 2004; 10(5): 494-501.
55. Wei HM, Wong P, Hsu LF, Shim W. Human bone marrow-derived adult stem
cells for post-myocardial infarction cardiac repair: Current status and future
directions. Singapore Med J. Oct 2009; 50(10): 935-942.
56. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann
H, Yu J, et al. Improved clinical outcome after intracoronary administration of
bone-marrow-derived progenitor cells in acute myocardial infarction: Final
1-year results of the REPAIR-AMI trial. Eur Heart J. Dec 2006; 27(23): 2775-2783.
57. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach
C, Fichtner S, et al. Intracoronary autologous bone-marrow cell transfer after
myocardial infarction: The BOOST randomised controlled clinical trial. Lancet.
Jul 10-16 2004; 364(9429): 141-148.
58. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, et al.
Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen
months' follow-up data from the randomized, controlled BOOST (BOne mar-
rOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation.
Mar 14 2006; 113(10): 1287-1294.
59. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-
Surma EK, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac
repair: A systematic review and meta-analysis. Arch Intern Med. May 28 2007;
167(10): 989-997.